Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (30)

2014

  1. Role of the mammalian target of rapamycin (mTOR) complexes in pancreatic β-cell mass regulation

    Vitamins and Hormones (Academic Press Inc.), pp. 425-469

2013

  1. Autophagy impairment aggravates the inhibitory effects of high glucose on osteoblast viability and function

    Biochemical Journal, Vol. 455, Núm. 3, pp. 329-337

  2. Papel del tejido adiposo marrón y perivascular en las complicaciones vasculares asociadas a la obesidad

    Clinica e Investigacion en Arteriosclerosis

2012

  1. Differential expression of senescence and cell death factors in non-small cell lung and colorectal tumors showing telomere attrition

    Oncology, Vol. 82, Núm. 3, pp. 153-164

  2. Methylation profiling in non-small cell lung cancer: Clinical implications

    International Journal of Oncology, Vol. 40, Núm. 3, pp. 739-746

2011

  1. Expression of human MDGA1 increases cell motility and cell-cell adhesion and reduces adhesion to extracellular matrix proteins in MDCK cells

    Cancer Microenvironment, Vol. 4, Núm. 1, pp. 23-32

2010

  1. MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway

    International Journal of Oncology, Vol. 36, Núm. 5, pp. 1209-1215

2008

  1. Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability

    Clinical Cancer Research, Vol. 14, Núm. 4, pp. 995-1001

  2. Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer

    Lung Cancer, Vol. 60, Núm. 3, pp. 416-425

2007

  1. Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer

    Oncology Reports, Vol. 17, Núm. 1, pp. 217-223

  2. Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma

    Hepato-Gastroenterology, Vol. 54, Núm. 73, pp. 315-319

  3. Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma

    Oncology Reports, Vol. 17, Núm. 6, pp. 1301-1307

2006

  1. Correlations of telomere length, telomerase activity, and telomerlc-repeat binding factor 1 expression in colorectal carcinoma: Prognostic indications

    Cancer, Vol. 106, Núm. 3, pp. 541-551

  2. Molecular biology in colorectal cancer

    Clinical and Translational Oncology, Vol. 8, Núm. 6, pp. 391-398

2005

  1. Characterization of MDGA1, a novel human glycosylphosphatidylinositol- anchored protein localized in lipid rafts

    Experimental Cell Research, Vol. 307, Núm. 1, pp. 91-99

  2. Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer

    Oncology Reports, Vol. 13, Núm. 1, pp. 115-120

2004

  1. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer

    Oncology Reports, Vol. 12, Núm. 3, pp. 621-629

  2. Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: Prognostic implications

    British Journal of Cancer, Vol. 90, Núm. 10, pp. 1983-1988

2002

  1. Genomic organization of a novel glycosylphosphatidylinositol MAM gene expressed in human tissues and tumors

    Oncogene, Vol. 21, Núm. 19, pp. 3089-3094

  2. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain

    International Journal of Cancer, Vol. 98, Núm. 5, pp. 774-779